- Forums
- ASX - By Stock
- RCE
- Ann: Phase I Clinical Trial of R327 I.V. - 6000mg Complete
Ann: Phase I Clinical Trial of R327 I.V. - 6000mg Complete, page-11
-
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RCE (ASX) to my watchlist
(20min delay)
|
|||||
Last
46.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $102.0M |
Open | High | Low | Value | Volume |
46.5¢ | 48.5¢ | 45.5¢ | $386.8K | 836.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 14910 | 46.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
45.5¢ | 15354 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 134410 | 0.455 |
11 | 209394 | 0.450 |
2 | 112000 | 0.445 |
6 | 176820 | 0.440 |
1 | 1500 | 0.435 |
Price($) | Vol. | No. |
---|---|---|
0.460 | 53485 | 4 |
0.465 | 14102 | 3 |
0.470 | 7262 | 2 |
0.475 | 1803 | 1 |
0.480 | 124896 | 3 |
Last trade - 15.57pm 15/07/2024 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online